Both trigger systemic inflammation and immune dysregulation, leading to symptoms such as fatigue, brain fog, headaches, joint pain, and anxiety
Notably, recent industry conferences such as the Obesity Week Conference, the American Diabetes Association (ADA) Scientific Sessions, and the European Association for the Study of Diabetes (EASD) Annual Meeting have served as pivotal platforms for presenting real-world evidence and clinical trial updates on Zepbound and other incretin-based therapies
Synaptic Neurosci
Pozzi M, Mazhar F, Peeters GGAM, Vantaggiato C, Nobile M, Clementi E, et al
Bone outcomes following sleeve gastrectomy in adolescents and young adults with obesity versus non-surgical controls
But as the popularity of these blockbuster medications grows 1 in 8 adults have taken a GLP-1 RA, according to a recent poll so will the research